Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dyn-Bioshaf Ltd.

Latest From Dyn-Bioshaf Ltd.

Start-Up News August 2007

In women's health, Novian offers a micro-invasive alternative to lumpectomy. Mirabilis Medica hopes to introduce a non-invasive in-office procedure for the removal of uterine fibroids. Dyn-Bioshaf believes that diagnostics that pinpoint the particular cause of infertility will ultimately help improve the success rates of the In Vitro Fertilization industry.
Medical Device

New Technologies for Infertility

The infertility market has historically been dominated by drugs. There have been few product opportunities on the medtech side, which has consisted of commodity products like syringes, petri dishes and microscopes. But that is changing; recently several new companies have been founded with technologies to improve the success rates of in vitro fertilization. VCs have also come to realize that infertility represents a premium, self-pay market for elective procedures.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Dyn-Bioshaf Ltd.
  • Senior Management
  • David Salton, CEO
  • Contact Info
  • Dyn-Bioshaf Ltd.
    Phone: (972) 4-6175442
    Caesarea Industrial Park
    7, Ha'eshel St.
    P.O. Box 3096 , 38000